Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Otsuka
Otsuka
Otsuka backs GrayMatters’ digital wearable tech for mental disorders
Pharmaforum
Fri, 01/14/22 - 11:00 am
Otsuka
GrayMatters Health
digital health
mental health
funding
Sunovion pens $890M Otsuka pact for a clutch of neuropsychiatric drugs
Fierce Biotech
Thu, 09/30/21 - 10:52 am
Sunovion
Otsuka
biobucks
neuropsychiatric
Otsuka 'Big Kidney' campaign targets HCPs in bid to shift diagnostic standards
Fierce Pharma
Mon, 03/1/21 - 11:06 am
kidney disease
Otsuka
physicians
autosomal dominant polycystic kidney disease
pharma marketing
Otsuka and Click Therapeutics Tap Verily to Go Remote with Trial
Medical Devices and Diagnostics Industry
Sun, 02/28/21 - 11:58 pm
Otsuka
Click Therapeutics
major depressive disorder
clinical trials
Verily
remote clinical trials
Otsuka, Click trial digital depression therapy with Google
Pharmaforum
Thu, 02/25/21 - 09:44 am
Otsuka
Click Therapeutics
Verily
Alphabet
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Thu, 12/17/20 - 06:18 pm
Aurinia Pharmaceuticals
lupus nephritis
GSK
Otsuka
Benlysta
Otsuka takes to YouTube, film and more to tackle the emerging mental health pandemic
Fierce Pharma
Mon, 10/19/20 - 10:37 am
Otsuka
mental health
pandemic
YouTube
Palladio bags $20 million Series B to topple a problematic kidney disease drug
Endpoints
Fri, 09/25/20 - 10:33 am
Palladio Biosciences
autosomal dominant polycystic kidney disease
kidney disease
lixivaptan
Otsuka
Samsca
Court approves Otsuka’s bid to buy Proteus for $15M
MedCity News
Fri, 08/21/20 - 12:34 pm
M&A
Otsuka
Proteus Digital Health
bankruptcy
patient adherence
Armed with FDA nod, Otsuka unit Astex preps to launch oral chemotherapy Inqovi
Fierce Pharma
Mon, 08/3/20 - 10:24 am
Otsuka
Astex
FDA
decitabine
blood cancer
FDA Approves At-Home Oral Therapy for MDS
Xtalks
Sat, 07/11/20 - 11:51 am
FDA
Inqovi
MDS
CMML
Otsuka
Astex
Proteus files for bankruptcy: Where did it falter?
MedCity News
Wed, 06/17/20 - 10:01 am
Proteus Digital Health
Otsuka
smart pills
bankruptcy
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
Xconomy
Wed, 03/11/20 - 07:26 pm
LSP
life sciences
Bristol-Myers Squibb
Otsuka
Europe
A forerunner in ‘smart pills’ adopts a new tack as key pharma partnership unravels
Stat
Tue, 01/14/20 - 10:03 am
smart pills
Proteus Digital Health
Otsuka
Otsuka's Avanir agrees to pay $108M over Neudexta kickbacks probe
Fierce Pharma
Thu, 09/26/19 - 07:44 pm
Avanir Pharmaceuticals
Otsuka
kickbacks
Neudexta
dementia
"Smart Pill" Schizophrenia Drug Unlikely To Move Payers
Forbes
Mon, 07/22/19 - 10:03 am
Otsuka
Abilify MyCite
smart pills
schizophrenia
payers
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Fri, 06/7/19 - 10:07 pm
Astex
Otsuka
clinical trials
ASTX727
myelodysplastic syndrome
CMML
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Tue, 05/21/19 - 11:07 pm
Verily
Alphabet
clinical trials
Pfizer
Novartis
Sanofi
Otsuka
Wockhardt receives US FDA approval for cancer drug
Pharmaceutical Business Review
Fri, 04/12/19 - 10:09 am
Wockhardt
decitabine
FDA
generics
Otsuka
Dacogen
myelodysplastic syndromes
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop
Motley Fool
Sat, 03/30/19 - 12:44 pm
Alzheimer's disease
Biogen
aducanumab
Otsuka
Axsome Therapeutics
Amgen
Novartis
Avanir
AVP-786
AXS-05
AMG520
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »